|

Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD

RECRUITINGN/ASponsored by Texas Tech University
Actively Recruiting
PhaseN/A
SponsorTexas Tech University
Started2025-01-07
Est. completion2026-08-31
Eligibility
Age50 Years – 120 Years
Healthy vol.Accepted
Locations1 site

Summary

This project aims to adapt, implement, and evaluate a Dialectical Behavior Therapy skills training group intervention for aging adult family caregivers of person with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) to reduce suicidality. By adapting this modality, the investigators will provide a scalable intervention tailored for this high-risk population, maximizing the public health impact and improving suicide prevention.

Eligibility

Age: 50 Years – 120 YearsHealthy volunteers accepted
Inclusion Criteria:

* being age 50 and over (as most informal caregivers of persons with AD/ADRD are 50 or older; AARP, 2020; Chi et al., 2019)
* being the primary informal caregiver
* living with an AD/ADRD-diagnosed patient
* being willing to be prodded for bloodspots
* demonstrating English-fluency
* endorsing a direct or indirect SI/suicide risk
* Eligible individuals will score above clinical cutoffs for SI/suicide risk on at least 1 of 3 measures: the Suicide Behavior Questionnaire-R (SBQ-R; score \> 6; Osman et al., 2002), Interpersonal Needs Question-naire (INQ; thwarted belonging score \> 35; and perceived burden \> 17; Mitchell et al., 2020) or the Geriatric De-pression Scale (GDS; score \> 5 Heisel et al., 2005).

Exclusion Criteria:

• Participants with neurocognitive impairment will be excluded (a Mini-Mental State Exam score ≤ 23; Folstein et al., 1975; Kochhann et al., 2010)

Conditions6

Alzheimer's DiseaseCaregiver BurdenDepressionInflammationPhysical HealthSuicide

Locations1 site

Garrison Institute on Aging
Lubbock, Texas, 79413
Jonathan D Singer, Ph.D.775-722-8066jonsinge@ttu.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.